These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34775585)

  • 1. The Association between Immediate Postpartum Depot Medroxyprogesterone Acetate Use and Postpartum Depressive Symptoms.
    Ross CM; Shim JY; Stark EL; Wisner KL; Miller ES
    Am J Perinatol; 2023 Dec; 40(16):1765-1769. PubMed ID: 34775585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of depot medroxyprogesterone acetate on postpartum depression.
    Tsai R; Schaffir J
    Contraception; 2010 Aug; 82(2):174-7. PubMed ID: 20654759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discordance between planned use and actual receipt of immediate postpartum depot medroxyprogesterone among low-income women.
    Brownell EA; Lussier MM; Dozier AM; Howard CR; Fisher SG; Duckett JW; Lawrence RA; Fernandez ID
    Breastfeed Med; 2014; 9(6):290-3. PubMed ID: 24893264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate.
    Civic D; Scholes D; Ichikawa L; LaCroix AZ; Yoshida CK; Ott SM; Barlow WE
    Contraception; 2000 Jun; 61(6):385-90. PubMed ID: 10958882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
    Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
    Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in users of depo-medroxyprogesterone acetate.
    Westhoff C; Wieland D; Tiezzi L
    Contraception; 1995 Jun; 51(6):351-4. PubMed ID: 7554975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
    Dahlberg K
    Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing depot medroxyprogesterone acetate access at a faith-based institution.
    Guiahi M; McNulty M; Garbe G; Edwards S; Kenton K
    Contraception; 2011 Sep; 84(3):280-4. PubMed ID: 21843694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.
    Chilvers CE
    Drug Saf; 1996 Sep; 15(3):212-8. PubMed ID: 8879975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of postpartum depot medroxyprogesterone administration among low-income mothers.
    Dozier AM; Nelson A; Brownell EA; Howard CR; Lawrence RA
    J Womens Health (Larchmt); 2014 Mar; 23(3):224-30. PubMed ID: 24443831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing Policy Change: A Study of Rapid Repeat Pregnancy in Adolescents to Increase Access to Immediate Postpartum Contraception.
    Qasba NT; Stutsman JW; Weaver GE; Jones KE; Daggy JK; Wilkinson TA
    J Womens Health (Larchmt); 2020 Jun; 29(6):815-818. PubMed ID: 31990605
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
    Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.